Neurology Diagnostics Devices Market
Neurology Diagnostics Devices Market Analysis By Product (Electroencephalogram, fMRI Systems, Optical Topography Systems, CT Scanners, Magnetoencephalography, Cerebral Oximetry Devices & Biomarker Tools) By Application & Region – Insights 2022 to 2032
Analysis of Neurology Diagnostics Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Neurology Diagnostics Devices Market Outlook (2022-2032)
At the end of 2021, the global neurology diagnostics devices market was valued at US$ 8.24 billion and is anticipated to reach US$ 21.1 billion by 2032, expanding at a high CAGR of 8.9% over the 2022-2032 time frame.
As per a detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, CT Scanners dominated the global market in 2021 accounting for 37.3% market share.
Sales of neurology diagnostics devices accounted for around 25% share of the global diagnostic imaging market in 2021.
Report Attribute |
Details |
---|---|
Neurology Diagnostics Devices Market Size (2021) |
US$ 8.24 Billion |
Estimated Market Value (2022) |
US$ 8.96 Billion |
Forecasted Market Value (2032) |
US$ 21.1 Billion |
Global Market Growth Rate (2022-2032) |
8.9% CAGR |
East Asia Market Share (2021) |
18.5% |
East Asia Market Growth Rate (2022-2032) |
10.6% CAGR |
China Market Growth Rate (2022-2032) |
10.2% CAGR |
Market Share of Top 5 Countries |
66% |
Key Market Players |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Neurology Diagnostics Devices (2012-2021) Vs. Market Outlook (2022-2032)
The global neurology diagnostics devices market expanded at a CAGR of 8% over the last nine years (2012-2021).
Sales of neurology diagnostics devices have been positively influenced by the rising prevalence of neurological disorders and increased focus on early diagnosis with the usage of reliable and safe devices for neurological treatment.
The focus of neurology is to diagnose and treat a wide range of brain and neurological disorders.
According to the most recent WHO survey (2021), neurological disorders such as stroke, Alzheimer's disease, epilepsy, and others account for more than 12% of all fatalities worldwide. It is also expected that by 2030, the number of years of life lost to neurological disorders will increase rapidly, from 95 million in 2015 to 103 million.
Additionally, it is anticipated that the global cost of neurological disorders alone was US$ 2.5 trillion in 2010, which will rise to US$ 6 trillion by 2030. The prevalence of neurological illnesses has significantly increased during the previous 25 years.
As such, Fact.MR expects the global neurology diagnostics devices market to be a fast-growing industry, with sales expected to surge at 8.9% CAGR over the forecast period (2022-2032).
What’s Mainly Driving Demand for Neurological Diagnostic Devices?
“Increasing Public Awareness Programs across Regions”
Patient care is the subject of numerous awareness campaigns, which is a key element in market growth. Globally, governments are putting more effort into promoting early detection, awareness, and recognition of the signs of neurological illnesses.
- The World Federation of Neurology (WFN) is taking the lead in supporting brain health awareness with the introduction of its Brain Health Initiative (BHI). This program is focused on providing in-depth knowledge on several issues, such as the significance of brain health and the consequences of brain dysfunction.
- In the U.S., the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS), and ten other national surgical associations jointly established a campaign to safeguard patients' access to care, in June 2020.
As a result, it is anticipated that increasing awareness will drive the demand for early neurology diagnosis, which will propel the market for neurology diagnostics devices in the years to come.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Opportunities for Key Suppliers of Neurology Diagnostics Devices?
“Collaborative Neuroscience Projects”
Besides having a substantial impact on medical science, the industrial economy, society, and other academic subjects, a new era of global neuroscience collaborations is establishing momentum.
- For instance, the American government has proposed a national brain science project and started the Brain Research through the Advancing Innovative Neurotechnologies (BRAIN) initiative. The International Brain Research Organization, along with many other national projects from Korea, China, Canada, and Australia joined this initiative shortly after it was launched as a complement to the Human Brain Project in the European Union.
What’s Restraining Neurology Diagnostics Devices Market Growth?
“Product Recalls Hurting Market Progress”
Patients and personnel utilizing neurology diagnostics devices could be at risk of health problems as a consequence of ongoing quality issues with medical devices and related recalls. The expense of replacing and fixing defective devices or compensating injured customers is borne by the organization or the manufacturer, which may affect its financial investments. Recalls tend to damage a company's reputation and result in losses of several billions of dollars.
- The FDA ordered Siemens Medical Systems Inc. to recall its SIEMENS SOMATOM, which uses the syngo CT VA30A SP4 software, in March 2022.
Software faults in models can lead to erratic problems that stop scanning processes, generate unexpected user warnings, and create artifacts in photos. Workflows for interventions might occasionally experience software problems.
Country-wise Insights
What is the U.S. Market Stance for Neurology Diagnostics Devices?
“Presence of Leading Players & High Regulatory Approvals”
The U.S. accounted for around 32 % share of the global neurology diagnostics devices market in 2021 owing to the presence of leading players such as General Electric, Canon Medical Systems Corporation, Siemens Medical Solutions USA, Inc., Masimo, and many others within the neurology space.
Additionally, the United States has highly-developed technological infrastructure that has helped it become a pioneer in technology and inspired many businesses to enter the market, thus aiding overall market expansion.
- For instance, Masimo's O3 regional oximetry device was approved by FDA in September 2020. The device monitors somatic tissue oxygenation saturation as well as relative changes in haemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. This marks an important step in assisting clinicians and researchers in further increasing their understanding of how the body utilises oxygen and in identifying organ hypoxemia.
Why is the U.K. a Lucrative Market for Neurology Diagnostics Device Manufacturers?
“Growing Prevalence of Neurological Disorders in the Country”
The U.K. accounted for 5.6% share of the global neurology diagnostics devices market in 2021.
The effects of neurological diseases are widespread.
- According to the Neurological Alliance Neuro Numbers 2019, there are reportedly 14.7 million cases of neurological disorders, which equates to one in every six citizens in the U.K. However, the annual spending on neurological diseases by NHS was reported to be around US$ 5.4 billion.
Rising disease prevalence will propel the country as a lucrative market for neurology diagnostics system manufacturers.
Which Factors are Fueling Demand for Neurology Diagnostics Devices in China?
“Growing Innovations Speeding Up Market Expansion”
China accounted for 14% of the global neurology diagnostics devices market share at the end of 2021.
- According to the "Made in China 2025" plan, the Chinese government wants the manufacturing of biomedical and luxury medical devices to increase rapidly.
Chinese domestic manufacturers are focusing on expanding the national economy by offering hospitals in the country less expensive local alternatives to imported medical goods.
A majority of domestic Chinese medical equipment makers' offerings have always been inexpensive and low-tech. The approach focuses on the creation of high-performance gadgets such as telemedicine equipment, wearable tech, entirely biodegradable cardiovascular stents, robotic surgery tools, and diagnostic imaging equipment.
The high-end medical devices market in China will continue to expand as local Chinese companies develop their technological skills, thus propelling the neurology diagnostics devices market in the country.
Category-wise Insights
Why is Demand for CT Scanners Gaining High Traction?
“Growing Advancements in Imaging Technology”
The CT scanners segment held the highest market share of 37.3% in 2021. The segment is expected to expand at 8.3% CAGR throughout the forecast period. This traction is being influenced by increasing advancements and the installation of CT scanners.
Recent improvements in CT scanning technology have reduced the hazardous radiation that patients are exposed to, along with allowing faster scan times and enhanced image quality. These factors have driven up the popularity of CT scanners in the market.
Which Application of Neurology Diagnostics Devices Brings in Higher Revenue?
“Rising Mental Health Issues Globally”
The mental health segment held 22.7% share of the global market in 2021.
A significant portion of the population is becoming more vulnerable to several mental health problems due to changing lifestyles, as well as a growing number of people falling under the geriatric age group suffering from several disorders, including multiple sclerosis, Parkinson's disease, brain tumours, epilepsy, dementia, and stroke.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Leading industry players in the field of neurology are currently focusing on expanding their operations into several nations across the globe. As part of their plan to hold onto their position in the market for neurology diagnostics devices globally, market players are also concentrating on innovation by developing and launching new products.
Collaborations and partnerships are major promotional strategies carried out by various key players.
- In January 2022, the Tianjin Normal University (TJNU) was awarded Compumedics Limited's first MEG contract in Asia. Over time, the installation of the new MEG system will build a strong centre of expertise for Compumedics in the significant and quickly expanding Chinese neurosciences industry.
- The National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC), EAST Hospital, and Canon Medical Systems Corporation have partnered to perform research using PCCT, commencing in August 2021. (photon counting computed tomography).
Similarly, recent developments related to companies manufacturing neurology diagnostics devices have been tracked by the team at Fact.MR, which are available in the full report.
Key Segments in Neurology Diagnostics Devices Industry Research
-
By Product :
- Electroencephalogram (EEG)
- fMRI Systems
- Optical Topography Systems (fNIRs)
- CT Scanners
- Magnetoencephalography (MEG)
- Cerebral Oximetry Devices
- Neuro-diagnostics Biomarker Tools
-
By Application :
- Cognitive Diagnosis
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Mental Health
- Stroke
- Concussion
- Dementia
- PTSD
- Other Neurological Diseases
-
By End User :
- Neurofeedback Clinics
- Neurology Clinics
- Hospitals
- Neurorehabilitation Centers
- Academic and Research Institutes
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Table of Content
1. Executive Summary 1.1. Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption Analysis 4.2. Product Features/ USPs Analysis 4.3. Regulatory Scenario 4.4. Reimbursement Scenario 4.5. PESTLE Analysis 4.6. Porter’s Analysis 4.7. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Market Outlook 5.1.3. Diagnostic Imaging Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising focus on Research and Development 5.2.2. Top Companies Historical Growth 5.2.3. Product Adoption Rate and Demand 5.2.4. Increasing burden of mental illnesses 5.2.5. Availability of various Product 5.2.6. COVID-19 impact 5.2.7. Increasing Demand of Treatment for Neurological Diseases 5.2.8. Increasing Market Consolidation Activities 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. 2021 Market Scenario 6.2. COVID-19 Impact Analysis 6.2.1. By Country 6.2.2. By Product 6.2.3. By Application 6.2.4. By End User 7. Neurology Diagnostics Devices Market Demand (in Volume in Units) Analysis 2012-2021 and Forecast, 2022–2032 7.1. Historical Market Value (US$ Mn) Analysis, 2012-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Neurology Diagnostics Devices Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Average Pricing Analysis Benchmark 8.3. Pricing Assumptions 9. Global Neurology Diagnostics Devices Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032 9.1. Historical Market Value (US$ Mn) Analysis, 2012-2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2012-2021 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032 10.3.1. Electroencephalogram (EEG) 10.3.2. fMRI Systems 10.3.3. Optical Topography Systems (fNIRs) 10.3.4. CT Scanners 10.3.5. Magnetoencephalography (MEG) 10.3.6. Cerebral Oximetry Devices 10.3.7. Neuro-diagnostics Biomarker Tools 10.4. Market Attractiveness Analysis By Product 11. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032 11.3.1. Cognitive Diagnosis 11.3.2. Attention-deficit/hyperactivity disorder (ADHD) 11.3.3. Mental Health 11.3.4. Stroke 11.3.5. Concussion 11.3.6. Dementia 11.3.7. PTSD 11.3.8. Others Neurological Diseases 11.4. Market Attractiveness Analysis By Application 12. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2012-2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 12.3.1. Neurofeedback Clinics 12.3.2. Neurology Clinics 12.3.3. Hospitals 12.3.4. Neurorehabilitation Centers 12.3.5. Academic and Research Institutes 12.4. Market Attractiveness Analysis By End User 13. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Volume (Units)Analysis, By Region, 2012-2021 13.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis By Region, 2022–2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa 13.4. Market Attractiveness Analysis By Region 14. North America Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012-2021 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2022–2032 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. U.S. Neurology Diagnostics Devices Market 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By Application 14.7.1.2.3. By End User 14.7.2. Canada Neurology Diagnostics Devices Market 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By Application 14.7.2.2.3. By End User 15. Latin America Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) a and Volume (Units) Analysis By Market Taxonomy, 2014–2021 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032 15.3.1. By Country 15.3.1.1. Mexico 15.3.1.2. Brazil 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. Mexico Neurology Diagnostics Devices Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By Application 15.7.1.2.3. By End User 15.7.2. Brazil Neurology Diagnostics Devices Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By Application 15.7.2.2.3. By End User 15.7.3. Argentina Neurology Diagnostics Devices Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Product 15.7.3.2.2. By Application 15.7.3.2.3. By End User 16. Europe Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012-2021 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2022–2032 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. U.K. 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Nordic Countries 16.3.1.8. Russia 16.3.1.9. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. Germany Neurology Diagnostics Devices Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By Application 16.7.1.2.3. By End User 16.7.2. France Neurology Diagnostics Devices Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By Application 16.7.2.2.3. By End User 16.7.3. Italy Neurology Diagnostics Devices Market 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By Application 16.7.3.2.3. By End User 16.7.4. Spain Neurology Diagnostics Devices Market 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast by Market Taxonomy 16.7.4.2.1. By Product 16.7.4.2.2. By Application 16.7.4.2.3. By End User 16.7.5. U.K. Neurology Diagnostics Devices Market 16.7.5.1. Introduction 16.7.5.2. Market Analysis and Forecast by Market Taxonomy 16.7.5.2.1. By Product 16.7.5.2.2. By Application 16.7.5.2.3. By End User 16.7.6. BENELUX Union Neurology Diagnostics Devices Market 16.7.6.1. Introduction 16.7.6.2. Market Analysis and Forecast by Market Taxonomy 16.7.6.2.1. By Product 16.7.6.2.2. By Application 16.7.6.2.3. By End User 16.7.7. Nordic Countries Neurology Diagnostics Devices Market 16.7.7.1. Introduction 16.7.7.2. Market Analysis and Forecast by Market Taxonomy 16.7.7.2.1. By Product 16.7.7.2.2. By Application 16.7.7.2.3. By End User 16.7.8. Russia Neurology Diagnostics Devices Market 16.7.8.1. Introduction 16.7.8.2. Market Analysis and Forecast by Market Taxonomy 16.7.8.2.1. By Product 16.7.8.2.2. By Application 16.7.8.2.3. By End User 17. South Asia Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Malaysia 17.3.1.4. Thailand 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. India Neurology Diagnostics Devices Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By Application 17.7.1.2.3. By End User 17.7.2. Indonesia Neurology Diagnostics Devices Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By Application 17.7.2.2.3. By End User 17.7.3. Malaysia Neurology Diagnostics Devices Market Analysis 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Product 17.7.3.2.2. By Application 17.7.3.2.3. By End User 17.7.4. Thailand Neurology Diagnostics Devices Market Analysis 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Product 17.7.4.2.2. By Application 17.7.4.2.3. By End User 18. East Asia Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 18.7. Country Level Analysis & Forecast 18.7.1. China Neurology Diagnostics Devices Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Product 18.7.1.2.2. By Application 18.7.1.2.3. By End User 18.7.2. Japan Neurology Diagnostics Devices Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Product 18.7.2.2.2. By Application 18.7.2.2.3. By End User 18.7.3. South Korea Neurology Diagnostics Devices Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Product 18.7.3.2.2. By Application 18.7.3.2.3. By End User 19. Oceania Neurology Diagnostics Devices Market 2017-2021 and Forecast 2022-2032 19.1. Introduction 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 19.7. Country Level Analysis & Forecast 19.7.1. Australia Neurology Diagnostics Devices Market Analysis 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Product 19.7.1.2.2. By Application 19.7.1.2.3. By End User 19.7.2. New Zealand Neurology Diagnostics Devices Market Analysis 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Product 19.7.2.2.2. By Application 19.7.2.2.3. By End User 20. Middle East and Africa (MEA) Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032 20.1. Introduction 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. South Africa 20.3.1.3. North Africa 20.3.1.4. Turkey 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Application 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Application 20.4.4. By End User 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 20.7. Country Level Analysis & Forecast 20.7.1. GCC Countries Neurology Diagnostics Devices Market Analysis 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast by Market Taxonomy 20.7.1.2.1. By Product 20.7.1.2.2. By Application 20.7.1.2.3. By End User 20.7.2. South Africa Neurology Diagnostics Devices Market Analysis 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast by Market Taxonomy 20.7.2.2.1. By Product 20.7.2.2.2. By Application 20.7.2.2.3. By End User 20.7.3. North Africa Neurology Diagnostics Devices Market Analysis 20.7.3.1. Introduction 20.7.3.2. Market Analysis and Forecast by Market Taxonomy 20.7.3.2.1. By Product 20.7.3.2.2. By Application 20.7.3.2.3. By End User 20.7.4. Turkey Neurology Diagnostics Devices Market Analysis 20.7.4.1. Introduction 20.7.4.2. Market Analysis and Forecast by Market Taxonomy 20.7.4.2.1. By Product 20.7.4.2.2. By Application 20.7.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Quanterix 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Key Financials 22.3.1.4. Sales Footprint 22.3.1.5. SWOT Analysis 22.3.1.6. Key Developments 22.3.1.7. Strategy Overview 22.3.1.7.1. Channel Strategy 22.3.1.7.2. Marketing Strategy 22.3.1.7.3. Product Strategy 22.3.2. Cadwell Laboratories Inc. 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Key Financials 22.3.2.4. Sales Footprint 22.3.2.5. SWOT Analysis 22.3.2.6. Key Developments 22.3.2.7. Strategy Overview 22.3.2.7.1. Channel Strategy 22.3.2.7.2. Marketing Strategy 22.3.2.7.3. Product Strategy 22.3.3. Hitachi Medical Systems 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Key Financials 22.3.3.4. Sales Footprint 22.3.3.5. SWOT Analysis 22.3.3.6. Key Developments 22.3.3.7. Strategy Overview 22.3.3.7.1. Channel Strategy 22.3.3.7.2. Marketing Strategy 22.3.3.7.3. Product Strategy 22.3.4. Canon Medical Systems Corporation 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Key Financials 22.3.4.4. Sales Footprint 22.3.4.5. SWOT Analysis 22.3.4.6. Key Developments 22.3.4.7. Strategy Overview 22.3.4.7.1. Channel Strategy 22.3.4.7.2. Marketing Strategy 22.3.4.7.3. Product Strategy 22.3.5. Compumedics Limited 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Key Financials 22.3.5.4. Sales Footprint 22.3.5.5. SWOT Analysis 22.3.5.6. Key Developments 22.3.5.7. Strategy Overview 22.3.5.7.1. Channel Strategy 22.3.5.7.2. Marketing Strategy 22.3.5.7.3. Product Strategy 22.3.6. Koninklijke Philips N.V. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Key Financials 22.3.6.4. Sales Footprint 22.3.6.5. SWOT Analysis 22.3.6.6. Key Developments 22.3.6.7. Strategy Overview 22.3.6.7.1. Channel Strategy 22.3.6.7.2. Marketing Strategy 22.3.6.7.3. Product Strategy 22.3.7. Medtronic plc. 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Key Financials 22.3.7.4. Sales Footprint 22.3.7.5. SWOT Analysis 22.3.7.6. Key Developments 22.3.7.7. Strategy Overview 22.3.7.7.1. Channel Strategy 22.3.7.7.2. Marketing Strategy 22.3.7.7.3. Product Strategy 22.3.8. Siemens AG 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Key Financials 22.3.8.4. Sales Footprint 22.3.8.5. SWOT Analysis 22.3.8.6. Key Developments 22.3.8.7. Strategy Overview 22.3.8.7.1. Channel Strategy 22.3.8.7.2. Marketing Strategy 22.3.8.7.3. Product Strategy 22.3.9. Nonin Medical, Inc. 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Key Financials 22.3.9.4. Sales Footprint 22.3.9.5. SWOT Analysis 22.3.9.6. Key Developments 22.3.9.7. Strategy Overview 22.3.9.7.1. Channel Strategy 22.3.9.7.2. Marketing Strategy 22.3.9.7.3. Product Strategy 22.3.10. Nihon Kohden Corporation 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Key Financials 22.3.10.4. Sales Footprint 22.3.10.5. SWOT Analysis 22.3.10.6. Key Developments 22.3.10.7. Strategy Overview 22.3.10.7.1. Channel Strategy 22.3.10.7.2. Marketing Strategy 22.3.10.7.3. Product Strategy 22.3.11. Masimo 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Key Financials 22.3.11.4. Sales Footprint 22.3.11.5. SWOT Analysis 22.3.11.6. Key Developments 22.3.11.7. Strategy Overview 22.3.11.7.1. Channel Strategy 22.3.11.7.2. Marketing Strategy 22.3.11.7.3. Product Strategy 22.3.12. Natus Medical Incorporated 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Key Financials 22.3.12.4. Sales Footprint 22.3.12.5. SWOT Analysis 22.3.12.6. Key Developments 22.3.12.7. Strategy Overview 22.3.12.7.1. Channel Strategy 22.3.12.7.2. Marketing Strategy 22.3.12.7.3. Product Strategy 22.3.13. General Electric Company 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Key Financials 22.3.13.4. Sales Footprint 22.3.13.5. SWOT Analysis 22.3.13.6. Key Developments 22.3.13.7. Strategy Overview 22.3.13.7.1. Channel Strategy 22.3.13.7.2. Marketing Strategy 22.3.13.7.3. Product Strategy 22.3.14. Elekta AB 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Key Financials 22.3.14.4. Sales Footprint 22.3.14.5. SWOT Analysis 22.3.14.6. Key Developments 22.3.14.7. Strategy Overview 22.3.14.7.1. Channel Strategy 22.3.14.7.2. Marketing Strategy 22.3.14.7.3. Product Strategy 22.3.15. Neurosoft, Inc. 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Key Financials 22.3.15.4. Sales Footprint 22.3.15.5. SWOT Analysis 22.3.15.6. Key Developments 22.3.15.7. Strategy Overview 22.3.15.7.1. Channel Strategy 22.3.15.7.2. Marketing Strategy 22.3.15.7.3. Product Strategy 22.3.16. EB Neuro S.p.A. 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Key Financials 22.3.16.4. Sales Footprint 22.3.16.5. SWOT Analysis 22.3.16.6. Key Developments 22.3.16.7. Strategy Overview 22.3.16.7.1. Channel Strategy 22.3.16.7.2. Marketing Strategy 22.3.16.7.3. Product Strategy 22.3.17. Ricoh USA Inc. 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Key Financials 22.3.17.4. Sales Footprint 22.3.17.5. SWOT Analysis 22.3.17.6. Key Developments 22.3.17.7. Strategy Overview 22.3.17.7.1. Channel Strategy 22.3.17.7.2. Marketing Strategy 22.3.17.7.3. Product Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 02: Global Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 03: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 04: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 05: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Region
Table 06: Global Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Region
Table 07: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 08: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 09: North America Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 10: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 11: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 12: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 13: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 14: Latin America Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 15: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 16: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 17: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 18: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 19: Europe Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 20: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 21: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 22: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 23: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 24: South Asia Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 25: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 26: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 27: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 28: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 29: East Asia Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 30: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 31: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 32: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 33: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 34: Oceania Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 35: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 36: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
Table 37: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country
Table 38: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 39: Middle East and Africa Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product
Table 40: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application
Table 41: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Neurology Diagnostics Devices Market Revenue Share by Product, 2021A & 2032F
Figure 02: Global Neurology Diagnostics Devices Market Revenue Share by Application, 2021A & 2032F
Figure 03: Global Neurology Diagnostics Devices Market Revenue Share by End User, 2021A & 2032F
Figure 04: Global Neurology Diagnostics Devices Market Revenue Share by Region, 2021A & 2032F
Figure 05: Global Neurology Diagnostics Devices Market Volume (Units) Analysis, 2012–2021
Figure 06: Global Neurology Diagnostics Devices Market Volume (Unit) & Y-o-Y Growth (%) Analysis, 2022–2032
Figure 07: Global Average Pricing Analysis Benchmark USD (Unit) (2021)
Figure 08: Global Neurology Diagnostics Devices, Pricing Analysis (US$) By Region, 2021
Figure 09: Global Neurology Diagnostics Devices, Pricing Analysis (US$) By Region, 2032
Figure 10: Global Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 11: Global Neurology Diagnostics Devices Market Forecast & Y-o-Y Growth, 2022–2032
Figure 12: Global Neurology Diagnostics Devices Market Absolute $ Opportunity, 2022 –2032
Figure 13: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By Product
Figure 14: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By Product
Figure 15: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By Product
Figure 16: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By Application
Figure 17: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By Application
Figure 18: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By Application
Figure 19: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By End User
Figure 20: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By End User
Figure 21: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By End User
Figure 22: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By Region
Figure 23: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By Region
Figure 24: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By Region
Figure 25: North America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 26: North America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 27: North America Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 28: North America Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 29: North America Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 30: North America Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 31: North America Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 32: North America Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 33: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 34: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 35: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 36: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 37: U.S. Neurology Diagnostics Devices Market Value Proportion Analysis, 2021
Figure 38: U.S. Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 39: U.S. Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 40: U.S. Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 41: Canada Neurology Diagnostics Devices Market Value Proportion Analysis, 2021
Figure 42: Canada Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 43: Canada Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 44: Canada Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 45: Latin America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 46: Latin America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 47: Latin America Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 48: Latin America Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 49: Latin America Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 50: Latin America Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 51: Latin America Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 52: Latin America Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 53: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 54: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 55: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 56: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 57: Brazil Market Value Proportion Analysis
Figure 58: Brazil Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 59: Brazil Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 60: Brazil Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 61: Mexico Market Value Proportion Analysis
Figure 62: Mexico Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 63: Mexico Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 64: Mexico Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 65: Argentina Market Value Proportion Analysis
Figure 66: Argentina Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 67: Argentina Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 68: Argentina Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 69: Europe Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 70: Europe Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 71: Europe Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 72: Europe Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 73: Europe Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 74: Europe Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 75: Europe Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 76: Europe Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 77: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 78: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 79: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 80: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 81: Germany Market Value Proportion Analysis
Figure 82: Germany Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 83: Germany Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 84: Germany Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 85: Italy Market Value Proportion Analysis
Figure 86: Italy Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 87: Italy Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 88: Italy Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 89: France Market Value Proportion Analysis
Figure 90: France Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 91: France Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 92: France Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 93: U.K. Market Value Proportion Analysis
Figure 94: U.K. Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 95: U.K. Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 96: U.K. Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 97: Spain Market Value Proportion Analysis
Figure 98: Spain Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 99: Spain Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 100: Spain Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 101: BENELUX Market Value Proportion Analysis
Figure 102: BENELUX Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 103: BENELUX Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 104: BENELUX Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 105: Russia Market Value Proportion Analysis
Figure 106: Russia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 107: Russia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 108: Russia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 109: Nordic Countries Market Value Proportion Analysis
Figure 110: Nordic Countries Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 111: Nordic Countries Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 112: Nordic Countries Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 113: South Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 114: South Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 115: South Asia Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 116: South Asia Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 117: South Asia Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 118: South Asia Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 119: South Asia Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 120: South Asia Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 121: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 122: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 123: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 124: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 125: India Market Value Proportion Analysis
Figure 126: India Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 127: India Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 128: India Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 129: Malaysia Market Value Proportion Analysis
Figure 130: Malaysia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 131: Malaysia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 132: Malaysia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 133: Indonesia Market Value Proportion Analysis
Figure 134: Indonesia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 135: Indonesia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 136: Indonesia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 137: Thailand Market Value Proportion Analysis
Figure 138: Thailand Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 139: Thailand Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 140: Thailand Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 141: East Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 142: East Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 143: East Asia Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 144: East Asia Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 145: East Asia Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 146: East Asia Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 147: East Asia Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 148: East Asia Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 149: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 150: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 151: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 152: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 153: China Market Value Proportion Analysis
Figure 154: China Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 155: China Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 156: China Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 157: Japan Market Value Proportion Analysis
Figure 158: Japan Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 159: Japan Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 160: Japan Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 161: South Korea Market Value Proportion Analysis
Figure 162: South Korea Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 163: South Korea Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 164: South Korea Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 165: Oceania Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 166: Oceania Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 167: Oceania Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 168: Oceania Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 169: Oceania Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 170: Oceania Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 171: Oceania Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 172: Oceania Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 173: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 174: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 175: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 176: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 177: Australia Market Value Proportion Analysis
Figure 178: Australia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 179: Australia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 180: Australia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 181: New Zealand Market Value Proportion Analysis
Figure 182: New Zealand Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 183: New Zealand Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 184: New Zealand Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 185: Middle East and Africa Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 186: Middle East and Africa Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F
Figure 187: Middle East and Africa Neurology Diagnostics Devices Market Value Analysis, 2012–2021
Figure 188: Middle East and Africa Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032
Figure 189: Middle East and Africa Neurology Diagnostics Devices Market Value Share By Product (2022E)
Figure 190: Middle East and Africa Neurology Diagnostics Devices Market Value Share By Application (2022E)
Figure 191: Middle East and Africa Neurology Diagnostics Devices Market Value Share By End User (2022E)
Figure 192: Middle East and Africa Neurology Diagnostics Devices Market Value Share By Country (2022E)
Figure 193: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By Product
Figure 194: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By Application
Figure 195: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By End User
Figure 196: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By Country
Figure 197: GCC Countries Market Value Proportion Analysis
Figure 198: GCC Countries Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 199: GCC Countries Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 200: GCC Countries Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 201: Turkey Market Value Proportion Analysis
Figure 202: Turkey Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 203: Turkey Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 204: Turkey Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 205: South Africa Market Value Proportion Analysis
Figure 206: South Africa Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 207: South Africa Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 208: South Africa Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Figure 209: North Africa Market Value Proportion Analysis
Figure 210: North Africa Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032
Figure 211: North Africa Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032
Figure 212: North Africa Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the revenue from the neurology diagnostics devices market?
The global neurology diagnostics devices market was worth US$ 8.24 billion in of 2021.
What is the demand outlook for neurology diagnostics devices?
The global market for neurology diagnostics systems is expected to reach US$ 21.1 billion by the end of 2032.
At what CAGR did the market expand over the past 9 years?
Revenue from the sales of neurology diagnostics devices increased at 8% CAGR from 2012 to 2021.
Which 5 countries account for the most demand for neurology diagnostics devices?
The U.S., China, India, Germany, and U.K. are witnessing the highest sales of neurology diagnostics equipment.
What is the market outlook for the U.S.?
The U.S. accounted for 93.4% share of the North American market in 2021.
At what percentage is demand for neurology diagnostics devices expected to register growth in Europe?
The European market is predicted to expand at 10% CAGR over the forecast period.
Who are the leading manufacturers of neurology diagnostics devices?
Top companies in the market are Siemens Medical Solutions USA, Inc., General Electric Company, FUJIFILM Holdings America Corporation, Canon Medical Systems USA, Koninklijke Philips N.V., Masimo, Medtronic plc., and Ricoh USA.
How is the market faring in South Korea and Japan?
The South Korean neurology diagnostics devices market is expected to exhibit 5.9% CAGR, and the Japanese market will surge at a value of 12.6% CAGR.
What growth rate is expected in India for neurology diagnostics devices?
The Indian market is set to expand rapidly at a CAGR of 7.3% through 2032.